bobbybobby
FeatureMarketsStocksJoin Us

Zscaler Stock Plunges 30%: Is This a Buy Opportunity?

May 28, 2026
Bobby Quant Team

💡 Key Takeaway

Zscaler's sharp sell-off appears to be a market overreaction to increased AI spending, creating a potential entry point for investors focused on its strong long-term growth in cloud security.

What Happened to Zscaler Stock?

Zscaler's stock price plummeted by 30% following its fiscal Q3 earnings report. The drop was not primarily due to poor results—revenue grew 25.5% to over $850 million, beating estimates—but rather the company's announcement of plans to significantly increase spending, particularly on AI initiatives.

The stock had rallied about 60% in the weeks leading up to the report, setting it up for a potential correction. By midday after the release, the sharp decline had pushed the stock into a price range ($120-$140) that has historically shown strong market support.

While the company raised its full-year revenue guidance and delivered a solid earnings beat, the market focused on a year-over-year decline in free cash flow, attributed to these accelerated investments in memory, compute, and storage. The company also faces integration challenges with its recent Red Canary acquisition and turnover in its sales team.

Despite the sell-off, analyst sentiment largely remains positive, with a 'Moderate Buy' consensus and price targets suggesting a double-digit rebound. Institutional investors, who own over 85% of the stock, have been net buyers in 2026, providing a potential floor for the price.

Why This Price Move Matters for Investors

The extreme reaction highlights the market's short-term focus on profitability metrics like cash flow, even when a company is investing for future growth. For Zscaler, this spending is aimed at cementing its position in the high-demand AI-driven cybersecurity market.

This creates a classic growth stock dilemma: near-term pain for potential long-term gain. The company is betting that current investments will lead to a more comprehensive, indispensable security platform, driving future market share and cash flow.

For the stock price, the key catalyst will be the recovery of free cash flow margins. The market is questioning the timing of this recovery, which may not materialize until 2027. Until then, the high valuation multiple leaves little room for execution missteps.

Ultimately, the sell-off may have disconnected the stock price from the company's solid fundamental performance and raised guidance. If Zscaler successfully executes its AI and integration strategy, the current price could represent a significant discount to its future value as a leader in cloud-native security.

Source: Investing.com
Analysis generated by Bobby AI quantitative model, reviewed and edited by our research team. This is not financial advice. Always do your own research before making investment decisions.

icon

Bobby Insight

bobby-insight

The severe sell-off presents a compelling buy-the-dip opportunity for patient investors with a multi-year horizon.

The core business remains strong with 25%+ revenue growth and raised guidance, while the spending causing the drop is an investment in future AI leadership. Analyst and institutional buying activity suggests the market overreacted, creating a potential value entry point.

What This Means for Me

means-for-me
If you hold ZS, this is a painful but likely temporary drawdown; consider whether your investment thesis remains intact based on long-term AI and cloud security trends. Investors with exposure to the broader cybersecurity sector (CRWD, PANW) should monitor for any spillover sentiment regarding growth spending versus profitability. For those looking to initiate a position in cloud security, this dip could offer a better risk/reward entry into a market leader.

Read More

Product

Partner

Markets

Stocks

© 2026 Flow AI Limited. All Rights Reserved.

Bobby, the world's first financial AI Agent, is developed by Flow AI, an AI-driven company. Flow AI is dedicated to providing global investors with AI-powered financial services across multiple markets.

Waffo.com Limited (authorised distributor): RM 1903, 19/F Lee Garden One, 33 Hysan Avenue, Causeway Bay, Hong Kong.

iconicon

What This Means for Me

If you hold ZS, this is a painful but likely temporary drawdown; consider whether your investment thesis remains intact based on long-term AI and cloud security trends. Investors with exposure to the broader cybersecurity sector (CRWD, PANW) should monitor for any spillover sentiment regarding growth spending versus profitability. For those looking to initiate a position in cloud security, this dip could offer a better risk/reward entry into a market leader.
Bobby
cs@bobby.ai
Bobby AI
RockFlow Platform
Stock Event
Macro Event
Industry Event
NVDA
AAPL
MSFT
AMZN
GOOG
META
TSLA
Privacy Policy
Terms of Use
iconicon

Stock to Watch

StocksImpactAnalysis
ZS
Positive
The 30% drop is framed as an overreution to necessary growth investments, with strong fundamentals, raised guidance, and institutional buying suggesting a rebound opportunity.
CRWD
Neutral
As a major competitor in cloud security, CrowdStrike could benefit if investors rotate out of ZS, but also faces similar market pressures for growth investment.
PANW
Neutral
Palo Alto Networks, another cybersecurity leader, may see relative strength if Zscaler's spending plans raise broader sector concerns about cash flow.
FTNT
Neutral
Fortinet, with a different hardware-focused model, might be viewed as a more stable alternative if software-centric cloud security stocks face valuation pressure.

Trade Desk Stock Crashes 52%: Buy the Dip?

Neutral Trade Desk's 52% drop reflects real risks like slowing growth and client disputes, but CEO insider buying suggests value for patient investors.

TTDPUBGYAMZN
Jul 10, 2026

Sandisk Rides SK Hynix Wave: Memory Boom Ahead?

Bullish Sandisk stock rose on SK Hynix's bullish memory shortage forecast, suggesting extended tailwinds for NAND and DRAM makers.

SNDKMU
Jul 10, 2026

AstraZeneca: Panic Selling or Smart Buy?

Bullish AstraZeneca's 5.7% drop on Wainua failure is an overreaction; the drug's ATTR-CM opportunity was only 2% of NPV, and the core business remains strong.

AZN
Jul 10, 2026